NIH-funded research R01 grant

Understanding insomnia during alcohol withdrawal through brain cell activity

Official title: Hypothalamic Neuronal Activity During Insomnia Induced by Chronic Ethanol Exposure

Funded at Medical University of South Carolina · NIH-11380979 · Data updated 2026-11-12

Researchers study how brain sleep and wake signals change during alcohol withdrawal in a mouse model to understand why insomnia occurs and how it might be treated.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMedical University of South Carolina
NIH-funded
Lab location1 site (Charleston, United States)
Project startSeptember 1, 2022
Project endJune 30, 2027
Funding year2026
Award (this year)$388,019
NIH project number5R01AA029129-05
Project IDNIH-11380979 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates: individuals experiencing insomnia associated with alcohol withdrawal and who are interested in future translational opportunities or related clinical trials.

Less likely to help

This study uses mice and basic neuroscience tools; it does not directly test therapies in people at this time.

What this research studies

This project uses a mouse model of chronic alcohol exposure to directly visualize activity in wake-promoting orexin neurons and sleep-promoting GABA neurons across waking and sleep states. By imaging Ca2+ signals with a miniscope during different sleep stages, the study aims to map imbalances that occur during withdrawal-induced insomnia. In addition, pharmacogenetic techniques will be used to probe the causal roles of these neurons and potential ways to restore balance and improve sleep. The work builds on preliminary findings showing increased activity in wake neurons and reduced activity in sleep neurons after chronic alcohol exposure. The ultimate goal is to identify targets that could lead to new strategies for relieving insomnia in individuals undergoing alcohol withdrawal.

Why it matters

Potential benefit: If successful, the research could point to brain-based targets or approaches to reduce insomnia during alcohol withdrawal, which may lessen relapse risk and improve recovery.

How similar studies have gone: Previous studies have shown links between orexin activity and wakefulness during withdrawal, supporting the plausibility of this approach.

Where this research is happening

  • Medical University of South Carolina
    Charleston, United States
    Active

Researchers

  • Principal investigator: Blanco-Centurion, Carlos a. — Medical University of South Carolina
  • Study coordinator: Blanco-Centurion, Carlos a.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.